Origins of Cystic Fibrosis Airway Disease
囊性纤维化气道疾病的起源
基本信息
- 批准号:10470203
- 负责人:
- 金额:$ 229.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-05 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP12A geneAddressAffectAirway DiseaseAnimal ModelAnionsBacteriaBicarbonatesBirthCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDefectDevelopmentDiseaseDisease ProgressionDuct (organ) structureExhibitsFamily suidaeGenetic DiseasesGlandGoalsH(+)-K(+)-Exchanging ATPaseHost DefenseHourHumanImpairmentInfectionInflammationInfrastructureInvestigationKnowledgeLeadLearningLifeLinkLiquid substanceLungLung diseasesMediatingMethodsMorbidity - disease rateMucociliary ClearanceMucous body substanceNewborn InfantPathogenesisPlayPropertyProton PumpProton-Translocating ATPasesProtonsPulmonary Cystic FibrosisRegulator GenesResearchResearch PersonnelRespiratory FailureRespiratory Tract InfectionsRoleSerumServicesSiteSurfaceTechniquesVirus Diseasesairway epitheliumairway obstructionairway surface liquidantimicrobialcystic fibrosis airwaydefined contributiondisease phenotypeearly cystic fibrosisgene discoveryinjured airwayinnovationinsightmortalitynovel therapeutic interventionnovel therapeuticsporcine modelpreventprogramsrecurrent infectionrespiratorysuccessvacuolar H+-ATPase
项目摘要
Twenty-eight years after the discovery of the CFTR gene, the causes of cystic fibrosis (CF) airway
disease remain controversial, we still lack answers to many critical questions, our therapies are
inadequate, and CF remains a life limiting and too often lethal disease. A major impediment to progress
has been lack of CF animal models with a lung disease phenotype resembling humans with CF. We
developed pigs with targeted alterations of the CFTR gene. CF pigs spontaneously develop the hallmark
features of CF lung disease, including airway infection, inflammation, airway wall remodeling, mucus
accumulation, and airway obstruction. Within hours of birth, CF pigs fail to eradicate bacteria as
effectively as wild-type pigs. At least two host defense defects, reduced antimicrobial activity in airway
surface liquid (ASL) and impaired mucociliary transport (MCT) contribute. Both were caused by
abnormally acidic airway liquid. In this Program three highly accomplished investigators will use CF pigs
to answer fundamental questions about CF lung disease. Together, the three projects will discover how
loss of CFTR function affects: a) submucosal gland function, the properties of mucus, and MCT; b) ASL
pH and proton secretion via ATP12A; and, c) small airways function, a likely site of CF disease
pathogenesis. The Project Leaders and their teams have an outstanding track record of collaborative CF
research, and here they sharpen their focus to a common goal. Their highly creative research is
supported by five cores that provide innovative infrastructure and services. By further educating CF
pathogenesis, it will accelerate discovery of novel therapies for this lethal disease.
发现CFTR基因的二十八年,囊性纤维化(CF)气道的原因
疾病仍然存在争议,我们仍然缺乏许多关键问题的答案,我们的疗法是
不足,CF仍然是生命的限制,而且常常是致命的疾病。进步的主要障碍
缺乏类似于人类的肺部疾病表型的CF动物模型。我们
开发了具有CFTR基因的靶向改变的猪。 CF猪自发发展标志
CF肺部疾病的特征,包括气道感染,炎症,气道墙重塑,粘液
积累和气道阻塞。出生后的几个小时内,CF猪无法消除细菌
有效地为野生型猪。至少有两个宿主防御缺陷,降低了气道抗菌活性
表面液体(ASL)和受损的粘膜纤毛运输(MCT)贡献。两者都是由
异常酸性气道液体。在这个计划中,三个高度成就的调查人员将使用CF猪
回答有关CF肺病的基本问题。这三个项目一起将发现如何
CFTR功能的丧失影响:a)粘膜粘膜函数,粘液的特性和MCT; b)ASL
pH和质子分泌通过ATP12A; c)小型气道功能,可能是CF疾病的一个部位
发病。项目负责人及其团队拥有协作CF的出色记录
研究,在这里,他们将重点放在一个共同的目标上。他们高度创造的研究是
由五个提供创新基础设施和服务的核心的支持。通过进一步教育CF
发病机理,它将加速这种致命疾病的新疗法。
项目成果
期刊论文数量(126)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cystic fibrosis transmembrane conductance regulator with a shortened R domain rescues the intestinal phenotype of CFTR-/- mice.
具有缩短的 R 结构域的囊性纤维化跨膜电导调节剂可挽救 CFTR-/- 小鼠的肠道表型。
- DOI:10.1073/pnas.1019752108
- 发表时间:2011
- 期刊:
- 影响因子:11.1
- 作者:Ostedgaard,LyndaS;Meyerholz,DavidK;Vermeer,DanielW;Karp,PhilipH;Schneider,Lindsey;Sigmund,CurtD;Welsh,MichaelJ
- 通讯作者:Welsh,MichaelJ
CFTR-deficient pigs display peripheral nervous system defects at birth.
CFTR 缺陷的猪在出生时表现出周围神经系统缺陷。
- DOI:10.1073/pnas.1222729110
- 发表时间:2013
- 期刊:
- 影响因子:11.1
- 作者:Reznikov,LeahR;Dong,Qian;Chen,Jeng-Haur;Moninger,ThomasO;Park,JungMin;Zhang,Yuzhou;Du,Jianyang;Hildebrand,MichaelS;Smith,RichardJH;Randak,ChristophO;Stoltz,DavidA;Welsh,MichaelJ
- 通讯作者:Welsh,MichaelJ
Antibacterial properties of the CFTR potentiator ivacaftor.
- DOI:10.1016/j.jcf.2014.02.004
- 发表时间:2014-09
- 期刊:
- 影响因子:0
- 作者:Reznikov LR;Abou Alaiwa MH;Dohrn CL;Gansemer ND;Diekema DJ;Stoltz DA;Welsh MJ
- 通讯作者:Welsh MJ
NETs and CF Lung Disease: Current Status and Future Prospects.
- DOI:10.3390/antibiotics4010062
- 发表时间:2015-01-15
- 期刊:
- 影响因子:0
- 作者:Gray RD;McCullagh BN;McCray PB
- 通讯作者:McCray PB
Cystic Fibrosis Transmembrane Conductance Regulator Potentiation as a Therapeutic Strategy for Pulmonary Edema: A Proof-of-Concept Study in Pigs.
囊性纤维化跨膜电导调节剂增强作为肺水肿的治疗策略:猪的概念验证研究。
- DOI:10.1097/ccm.0000000000002720
- 发表时间:2017
- 期刊:
- 影响因子:8.8
- 作者:Li,Xiaopeng;VargasBuonfiglio,LuisG;Adam,RyanJ;Stoltz,DavidA;Zabner,Joseph;Comellas,AlejandroP
- 通讯作者:Comellas,AlejandroP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A STOLTZ其他文献
FATAL LUNG INJURY SECONDARY TO TRIMETHOPRIM-SULFAMETHOXAZOLE
- DOI:
10.1016/j.chest.2023.07.1615 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
HALEY PYSICK;DAVID A STOLTZ - 通讯作者:
DAVID A STOLTZ
DAVID A STOLTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A STOLTZ', 18)}}的其他基金
Climate Change and Lung Health Training Program
气候变化与肺部健康培训计划
- 批准号:
10556149 - 财政年份:2023
- 资助金额:
$ 229.33万 - 项目类别:
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health
测试气道粘膜下腺和表面上皮对肺部健康的贡献
- 批准号:
10597111 - 财政年份:2022
- 资助金额:
$ 229.33万 - 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
- 批准号:
10155587 - 财政年份:2017
- 资助金额:
$ 229.33万 - 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
- 批准号:
9289053 - 财政年份:2017
- 资助金额:
$ 229.33万 - 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
- 批准号:
9918957 - 财政年份:2017
- 资助金额:
$ 229.33万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics
解码小鼠 Pkhd1 模型中的肾脏保护机制:对 ARPKD 治疗的影响
- 批准号:
10170340 - 财政年份:2020
- 资助金额:
$ 229.33万 - 项目类别:
Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics
解码小鼠 Pkhd1 模型中的肾脏保护机制:对 ARPKD 治疗的影响
- 批准号:
10614404 - 财政年份:2020
- 资助金额:
$ 229.33万 - 项目类别:
Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics
解码小鼠 Pkhd1 模型中的肾脏保护机制:对 ARPKD 治疗的影响
- 批准号:
10382438 - 财政年份:2020
- 资助金额:
$ 229.33万 - 项目类别: